| Literature DB >> 13893193 |
Abstract
In a double-blind study, 106 mentally retarded patients with speech defects were given 15 mg. of d-Amphetamine daily, or a placebo, for a three-month period. Speech defect types were: Stuttering, immature production, oral inaccuracy, lisp, psychotic, mongoloid, aphasia, deafness, and cleft palate. Only the stutterers showed obvious improvement in comparison with the placebo group. Three severe, long-term stutterers showed such dramatic improvement that their whole course in life has been changed.Entities:
Keywords: AMPHETAMINE/therapy; MENTAL DEFICIENCY/therapy; SPEECH DISORDERS/therapy
Mesh:
Substances:
Year: 1962 PMID: 13893193 PMCID: PMC1574858
Source DB: PubMed Journal: Calif Med ISSN: 0008-1264